|
Archived Monthly Oncology Tumor Boards: Management of Thyroid Carcinomas |
1.00 |
10/02/2023 - 12:00am to 10/02/2024 - 12:00am |
|
Monthly Oncology Tumor Boards: B-Cell Lymphomas: Histologic Transformation of Indolent Lymphomas |
1.00 |
03/19/2024 - 12:00am to 08/04/2024 - 12:00am |
|
NCCN Guidelines® Insights - Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024 |
1.00 |
10/10/2023 - 12:00am to 10/10/2024 - 12:00am |
|
Archived Monthly Oncology Tumor Boards: Identification and Management of Immuno-Oncology Targeted Therapy-Related Adverse Events in Renal Cell... |
1.00 |
10/26/2023 - 12:00am to 10/26/2024 - 12:00am |
|
Bone Disease Management and Infections in Multiple Myeloma |
1.00 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
|
Recorded Presentation from the NCCN Pharmacy Updates: Updates in the Treatment of Adult Acute Lymphoblastic Leukemia |
1.00 |
12/21/2023 - 12:00am to 12/20/2024 - 11:59pm |
|
Recorded Presentation from the NCCN Pharmacy Updates: The Growing Impact of Pharmacogenomics Across the Oncology Landscape |
1.00 |
03/21/2024 - 12:00am to 03/21/2025 - 12:00am |
|
NCCN Guidelines® Insights - B-Cell Lymphomas, Version 6.2023 |
1.00 |
11/10/2023 - 12:00am to 11/10/2024 - 12:00am |
|
Recorded Presentation from the NCCN Pharmacy Updates: Oncology Stewardship: Best Practices for Pharmacists in Optimizing Patient Safety and Quality... |
1.00 |
05/02/2024 - 12:00am to 05/02/2025 - 12:00am |
|
NCCN Guidelines® Insights - Cervical Cancer, Version 1.2024 |
1.00 |
12/10/2023 - 12:00am to 12/10/2024 - 12:00am |
|
Revolutionizing Hematologic Cancer Treatment: The Promise of Bispecific T-Cell Engagers |
1.00 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
|
NCCN Pharmacy Updates: The Growing Impact of Pharmacogenomics Across the Oncology Landscape |
1.00 |
01/29/2024 - 12:00am to 05/31/2024 - 12:00am |
|
Archived Monthly Oncology Tumor Boards: Systemic Therapy for Metastatic Prostate Cancer |
1.00 |
05/02/2024 - 12:00am to 05/02/2025 - 12:00am |
|
Navigating the Challenges: Effective Management of Toxicities in CAR T-Cell Therapies |
1.00 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
|
Individualized Multidisciplinary CLL/SLL Care: Practical Application of Guidelines and Emerging Data |
1.00 |
02/09/2024 - 12:00am to 02/09/2025 - 12:00am |
Facebook
Twitter
LinkedIn
Forward